Ledger.Open graph →
SEC Form D · filed February 26, 2025

Bambusa Therapeutics, Inc

Offering
$88.9M
Sold
$53.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Helmut Jeggle · Boston, MADirectorShanshan Xu · Boston, MAExec · Director · PromoterShanshan Xu · Boston, MAExec · Director · PromoterHelmut Jeggle · Boston, MADirectorSean Marett · Mainz, 2MDirectorDerek Dirocco · South San Francisco, CADirectorTeisha Vandekop · Meridian, TXDirectorGary Tickel · San Marino, CAExec · Director · PromoterSean Marett · Mainz, 2MDirectorDerek Dirocco · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗